- Home
- » Tags
- » Andexanet alfa
Top View
- Current Evidence for Pharmacologic Reversal Using Direct Oral Anticoagulants: What’S
- CONCLUSION How Should Canadian Pharmacy Departments Utilize
- Direct Oral Anticoagulant Reversal: How, When and Issues Faced М Mikhail S
- Augusta: Beautiful from Amen Corner
- Virginia DUR Quarterly Newsletter
- PDF Download
- The Interactions of Nintedanib and Oral Anticoagulants—Molecular Mechanisms and Clinical Implications
- 2018 Medicines in Development for Heart Disease and Stroke
- Anatomical Classification Guidelines V2018 EPHMRA ANATOMICAL
- SWL CCG Commissioned Pbr Excluded Drug/Device List 2020/2021
- Drug-Induced Diseases
- EMRA and ACMT Medical Toxicology Guide References GLOBAL 1
- Quarterwatch 16Q4
- ICU Resident's Guide
- Poisons and Poisoning
- ASHP INJECTABLE DRUG INFORMATION Index 1723
- Commissioned List of Indications 2021-2022
- Essential Medicines, Medical Countermeasures, and Critical Inputs for the List Described in Section 3(C) of the Executive Order 13944
- Study Protocol
- ATC-Index Mit DDD-Angaben Für Deutschland Im Jahre 2019
- Special Interest Articles MARCH 2019 Regional Poison Control Center
- Winter 2019, Spring2019, 2017, Issue Issue Issue 810 10
- Chenshan Zhou, Pharmd October 30, 2018 New Drugs on the Block: Novel Therapies in Critical Care
- CHMP Agenda of the 28-30 April 2020 Meeting
- Download Article
- Andexanet Alfa (ANDEXXA®) Pharmacist Guideline for Use
- Spring 2016, Issue 7
- Mustknow New Drugs
- Copyright © 2020 Wolters Kluwer Health, Inc. All Rights Reserved. Direct Oral Anticoagulant Reversal: an Update
- New Anesthesia Drugs Already Here Or on the Horizon
- The Clinical Insight
- Andexanet Alfa*
- TAG Mail – 17 Dec 2020
- Swiss Public Assessment Report
- Antidotes for Reversal of Direct Oral Anticoagulants
- Mrx CLINICAL ALERT
- Managing Blooding Patients on Warfarin Vs the New Anticoagulants
- California 3 Tier with Specialty Drug List
- DRAFT COMPARISON of the WHO ATC CLASSIFICATION & Ephmra
- Know the New: 2018 Novel Drug Approvals
- Appendix 1: Advanced Antidote List
- NOAC Antidotes Who Were Taking Rivaroxaban Or Apixaban, Respectively
- Volume 4, Issue 8
- (Generic) Drug Names Appear in Bold Type; Brand (Proprietary, Trade) Names Appear in Regular Type
- Vancomycin Dosing: from Trough to AUC/MIC